TsontchoAlexandrovIanchulevMDMPH

Ophthalmology • New York, NY

Cataract Related, Glaucoma Related

Professor of Ophthalmology Director of Technology and Innovation

Join to view full profile

Dr. Ianchulev is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ianchulev's full profile

Already have an account?

Office
310 E 14th St
Ste 319
New York, NY 10003
Phone+1 617-216-4369

Fax+1 332-237-5156

Education & Training

University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Ophthalmology, 2000 - 2003
Harvard Medical SchoolClass of 1999

Certifications & Licensure

NY State Medical License 2015 - 2025
CA State Medical License 2001 - 2019
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

Fellow (FAAO) American Academy of Ophthalmology

Clinical Trials

A Study to Evaluate Ranibizumab in Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD) Start of enrollment: 2005 Nov 01
Completed
Phase 3
CyPass Clinical Experience Study Start of enrollment: 2009 Dec 01
Completed
Safety and Performance Study of the CyPass System Applier Model 241 Start of enrollment: 2014 Aug 01
Completed
Safety and Efficacy of Phenylephrine 2.5%-Tropicamide 1% Microdose Ophthalmic Solution for Pupil Dilation Start of enrollment: 2018 Dec 01
Completed
Phase 3
Safety and Efficacy of Phenylephrine 2.5%-Tropicamide 1% Microdose Ophthalmic Solution for Pupil Dilation Start of enrollment: 2018 Nov 15
Completed
Phase 3
Microdosed Atropine 0.1% and 0.01% Ophthalmic Solutions for Reduction of Pediatric Myopia Progression Start of enrollment: 2019 Jun 03
Recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

1032 citations
Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study
David M. Brown, Mark Michels, Peter K. Kaiser, Jeffrey S. Heier, Judy P. Sy
Ophthalmology. 2009-01-01
66 citations
Cerebrovascular accidents in patients treated for choroidal neovascularization with ranibizumab in randomized controlled trials.
Neil M. Bressler, David S. Boyer, David F. Williams, Steven M. Butler, Steven Francom
Retina. 2012-10-01
31 citations
Peristat: A Computer-Based Perimetry Self-Test for Cost-Effective Population Screening of Glaucoma
Tsontcho Ianchulev, Peter Pham, Vladimir Makarov, Brian A. Francis, Don S. Minckler
Current Eye Research. 2005-01-01

Journal Articles

Supraciliary Microstent Implantation for Open-Angle Glaucoma: Multicentre 3-Year Outcomes
Tsontcho Ianchulev, MD, Emergency Medicine Journal

Press Mentions

Get Inspired by Our Special Guest Dr. Tsontcho IanchulevApril 8th, 2021
Wouldn’t It Be Great if Eyedrops Didn’t Spill Out of Your Eyes?November 14th, 2017
Microdosing Tech Means Less Wasted Eye MedicationNovember 14th, 2017
Join now to see all

Professional Memberships

American Academy of Ophthalmology - AAO
Fellow

Other Languages

Spanish, German, Russian